| Date Filed | Type | Description |
| 03/24/2023 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 1,924,464 shares
@ $0
Granted 1,492,200 options to buy
@ $5.04, valued at
$7.5M
|
|
| 03/16/2023 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 22,340 shares
@ $5.56, valued at
$124.2k
|
|
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/25/2022 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 2,195,512 options to buy
@ $9.69, valued at
$21.3M
|
|
| 03/17/2022 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 23,648 shares
@ $7.6488, valued at
$180.9k
|
|
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4/A
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Gifted 205,778 shares
@ $0
Gifted 205,778 shares
@ $0 |
|
| 03/30/2021 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 80,452 shares
@ $0
Granted 298,836 options to buy
@ $33.78, valued at
$10.1M
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2020 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,198 shares
@ $0
Acquired 9,187 shares
@ $0
Gifted 428,022 shares
@ $0
Gifted 428,022 shares
@ $0 |
|
| 03/20/2020 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 568,600 options to buy
@ $18.22, valued at
$10.4M
|
|
| 03/18/2020 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 18,710 shares
@ $19.2417, valued at
$360k
Sold 1,625 shares
@ $20.0634, valued at
$32.6k
|
|
| 03/11/2020 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 11/21/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 10/29/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 09/25/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 09/09/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 07/22/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 9,402 shares
@ $0
Acquired 9,391 shares
@ $0 |
|
| 07/12/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 10,154 shares
@ $0
Acquired 6,388 shares
@ $0 |
|
| 05/15/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Acquired 11,753 shares
@ $0 |
|
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2019 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 173,000 shares
@ $0
Granted 292,700 options to buy
@ $26.89, valued at
$7.9M
|
|
| 10/17/2018 |
4
| Chang David D (President and CEO) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Bought 40,000 shares
@ $18, valued at
$720k
Converted 29,946 shares
@ $0
Converted 5,704 convertible preferred
@ $0 |
|
| 10/10/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Chang David D (EVP, R&D, Chief Medical Off.) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 691 shares
@ $78.53, valued at
$54.3k
Sold 3,939 shares
@ $79.63, valued at
$313.7k
Sold 2,424 shares
@ $80.44, valued at
$195k
Sold 3,549 shares
@ $82, valued at
$291k
Sold 8,697 shares
@ $82.6, valued at
$718.4k
Sold 700 shares
@ $83.66, valued at
$58.6k
Exercised 20,000 options to buy
@ $6.89, valued at
$137.8k
|
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |